Login to Your Account



Flagship Venturelabs' start-up Rubius moving RCTs toward clinic

By Jennifer Boggs
Managing Editor

Thursday, December 31, 2015

Armed with an initial $25 million investment from Flagship Ventures, Rubius Therapeutics Inc. is on its way to the clinic with a new therapeutic modality designed to harness the natural ability of red blood cells to interact with and modulate the immune system.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription